Literature DB >> 79086

Dopamine and schizophrenia. A therapy revisited and revised.

F A Henn.   

Abstract

Evidence is presented for a modulatory role for dopamine in the C.N.S. and for an indirect rather than a direct involvement of dopaminergic systems in the production of schizophrenic symptoms. The fine structure of dopaminergic fibres indicates that a majority of presynaptic boutons are not in close juxtaposition with postsynaptic neuronal membranes. This points to a wider distribution of receptors than localisation to dense postsynaptic membrane. Preliminary studies of receptor localisation support this conclusion, providing indirect evidence for autoreceptors and evidence for localisation, in the glia, of a substantial number of receptors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 79086     DOI: 10.1016/s0140-6736(78)91693-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

1.  An astroglia-linked dopamine D2-receptor action in prefrontal cortex.

Authors:  Z U Khan; P Koulen; M Rubinstein; D K Grandy; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Receptor studies on isolated astroglial cell fractions prepared with and without trypsin.

Authors:  F A Henn; J Deering; D Anderson
Journal:  Neurochem Res       Date:  1980-04       Impact factor: 3.996

3.  The release of endogenous dopamine and its metabolites from rat striatum as detected in push-pull perfusates: effects of systematically administered drugs.

Authors:  F S Radhakishun; J Korf; K Venema; B H Westerink
Journal:  Pharm Weekbl Sci       Date:  1983-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.